PTPN11 and hepatocellular carcinoma: For instance, in hepatocellular carcinoma (HCC), miR−186 markedly enhanced the apoptosis rate of cisplatin-treated HCC cells by targeting PTPN11 and elevating the expression of apoptosis-related proteins [27].